The main component is Hericium erinaceus mycelium, which is clinically used to treat gastric cancer, esophageal cancer, duodenal ulcer and chronic gastritis, and has a certain palliative effect.

It is a sugar-coated tablet, which is brown, slightly fragrant and slightly bitter after removing the sugar coating.

Oral: 4-8 tablets each time, 3 times a day 1.

No adverse reaction was found in clinical observation.